156 related articles for article (PubMed ID: 9527790)
1. TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus.
Uckun FM; Chelstrom LM; Tuel-Ahlgren L; Dibirdik I; Irvin JD; Langlie MC; Myers DE
Antimicrob Agents Chemother; 1998 Feb; 42(2):383-8. PubMed ID: 9527790
[TBL] [Abstract][Full Text] [Related]
2. Toxicity, biological activity, and pharmacokinetics of TXU (anti-CD7)-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus.
Uckun FM; Bellomy K; O'Neill K; Messinger Y; Johnson T; Chen CL
J Pharmacol Exp Ther; 1999 Dec; 291(3):1301-7. PubMed ID: 10565855
[TBL] [Abstract][Full Text] [Related]
3. In vivo toxicity, pharmacokinetics, and antileukemic activity of TXU (anti-CD7)-pokeweed antiviral protein immunotoxin.
Waurzyniak B; Schneider EA; Tumer N; Yanishevski Y; Gunther R; Chelstrom LM; Wendorf H; Myers DE; Irvin JD; Messinger Y; Ek O; Zeren T; Langlie MC; Evans WE; Uckun FM
Clin Cancer Res; 1997 Jun; 3(6):881-90. PubMed ID: 9815763
[TBL] [Abstract][Full Text] [Related]
4. Large scale manufacturing of TXU(anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate for clinical trials.
Myers DE; Jun X; Clementson D; Donelson R; Sicheneder A; Hoffman N; Bell K; Sarquis M; Langlie MC; Turner N; Uckun FM
Leuk Lymphoma; 1997 Oct; 27(3-4):275-302. PubMed ID: 9402326
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design and engineering of a nontoxic recombinant pokeweed antiviral protein with potent anti-human immunodeficiency virus activity.
Uckun FM; Rajamohan F; Pendergrass S; Ozer Z; Waurzyniak B; Mao C
Antimicrob Agents Chemother; 2003 Mar; 47(3):1052-61. PubMed ID: 12604541
[TBL] [Abstract][Full Text] [Related]
6. Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral protein.
Erice A; Balfour HH; Myers DE; Leske VL; Sannerud KJ; Kuebelbeck V; Irvin JD; Uckun FM
Antimicrob Agents Chemother; 1993 Apr; 37(4):835-8. PubMed ID: 8494381
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV agents. TXU-PAP--early results.
TreatmentUpdate; 2000 Feb; 12(1):2. PubMed ID: 12125626
[No Abstract] [Full Text] [Related]
8. In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency.
Gunther R; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Uckun FM
Leukemia; 1993 Feb; 7(2):298-309. PubMed ID: 7678882
[TBL] [Abstract][Full Text] [Related]
9. Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide.
Jansen B; Kersey JH; Jaszcz WB; Gunther R; Nguyen DP; Chelstrom LM; Tuel-Ahlgren L; Uckun FM
Leukemia; 1993 Feb; 7(2):290-7. PubMed ID: 7678881
[TBL] [Abstract][Full Text] [Related]
10. Pokeweed antiviral protein isoforms PAP-I, PAP-II, and PAP-III depurinate RNA of human immunodeficiency virus (HIV)-1.
Rajamohan F; Venkatachalam TK; Irvin JD; Uckun FM
Biochem Biophys Res Commun; 1999 Jul; 260(2):453-8. PubMed ID: 10403789
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Manivel C; Arthur D; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Gunther R
Blood; 1992 May; 79(9):2201-14. PubMed ID: 1373967
[TBL] [Abstract][Full Text] [Related]
12. Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide.
Uckun FM; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Manivel C; Irvin JD; Myers DE; Gunther R
Blood; 1992 Jun; 79(12):3116-29. PubMed ID: 1375841
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice.
Terenzi A; Bolognesi A; Pasqualucci L; Flenghi L; Pileri S; Stein H; Kadin M; Bigerna B; Polito L; Tazzari PL; Martelli MF; Stirpe F; Falini B
Br J Haematol; 1996 Mar; 92(4):872-9. PubMed ID: 8616080
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 replication in seropositive patients' CD4+ T-cells by pokeweed antiviral protein-monoclonal antibody conjugates.
Zarling JM; Moran PA; Haffar O; Diegel M; Myers DE; Kuelbeck V; Ledbetter JA; Uckun FM
Int J Immunopharmacol; 1991; 13 Suppl 1():63-8. PubMed ID: 1688086
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic features, immunogenicity, and toxicity of B43(anti-CD19)-pokeweed antiviral protein immunotoxin in cynomolgus monkeys.
Uckun FM; Yanishevski Y; Tumer N; Waurzyniak B; Messinger Y; Chelstrom LM; Lisowski EA; Ek O; Zeren T; Wendorf H; Langlie MC; Irvin JD; Myers DE; Fuller GB; Evans W; Gunther R
Clin Cancer Res; 1997 Mar; 3(3):325-37. PubMed ID: 9815689
[TBL] [Abstract][Full Text] [Related]
16. CNS activity of Pokeweed anti-viral protein (PAP) in mice infected with lymphocytic choriomeningitis virus (LCMV).
Uckun FM; Rustamova L; Vassilev AO; Tibbles HE; Petkevich AS
BMC Infect Dis; 2005 Feb; 5():9. PubMed ID: 15725345
[TBL] [Abstract][Full Text] [Related]
17. Deguanylation of human immunodeficiency virus (HIV-1) RNA by recombinant pokeweed antiviral protein.
Rajamohan F; Kurinov IV; Venkatachalam TK; Uckun FM
Biochem Biophys Res Commun; 1999 Sep; 263(2):419-24. PubMed ID: 10491308
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal inhibitory proteins from plants inhibit HIV-1 replication in acutely infected peripheral blood mononuclear cells.
Olson MC; Ramakrishnan S; Anand R
AIDS Res Hum Retroviruses; 1991 Dec; 7(12):1025-30. PubMed ID: 1725958
[TBL] [Abstract][Full Text] [Related]
19. High resolution X-ray structure of potent anti-HIV pokeweed antiviral protein-III.
Kurinov IV; Uckun FM
Biochem Pharmacol; 2003 May; 65(10):1709-17. PubMed ID: 12754107
[TBL] [Abstract][Full Text] [Related]
20. Expression of biologically active recombinant pokeweed antiviral protein in methylotrophic yeast Pichia pastoris.
Rajamohan F; Doumbia SO; Engstrom CR; Pendergras SL; Maher DL; Uckun FM
Protein Expr Purif; 2000 Mar; 18(2):193-201. PubMed ID: 10686150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
